Find clinical trials for Non-Hodgkin Lymphoma in Los Angeles, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Los Angeles, CA, USA:
radiotherapy in participants with relapsed or refractory non-Hodgkin's lymphoma (NHL). Two dose levels of SIRPant-M are be...
Phase 1
Duarte, California, United States and 2 other locations
to Standard Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracyc...
Phase 3
Los Angeles, California, United States and 66 other locations
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Los Angeles, California, United States and 89 other locations
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Downey, California, United States and 31 other locations
1/2 study to evaluate the safety profile, tolerability of IPH6501, and determine the recommended phase 2 dose (RP2D) for patients with B-Cell non...
Phase 1, Phase 2
Los Angeles, California, United States and 11 other locations
CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...
Phase 1
Los Angeles, California, United States and 37 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Santa Monica, California, United States and 56 other locations
drugs less effective or could lead to side effects)* To find out how well the study drugs work against relapsed or refractory aggressive B-cell non...
Phase 1
Santa Monica, California, United States and 19 other locations
(N-803) and Rituximab in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma. Up to 20 subjects will be enrolled and ra...
Phase 1
Newport Beach, California, United States
A Phase 1 Study Evaluating BAFFR-targeting CAR T Cells for Patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma...
Phase 1
Duarte, California, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal